• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类“保护蛋白”的三维结构:前体形式的结构提示了一种复杂的激活机制。

Three-dimensional structure of the human 'protective protein': structure of the precursor form suggests a complex activation mechanism.

作者信息

Rudenko G, Bonten E, d'Azzo A, Hol W G

机构信息

Department of Biological Structure, School of Medicine, University of Washington, Seattle 98195-7742, USA.

出版信息

Structure. 1995 Nov 15;3(11):1249-59. doi: 10.1016/s0969-2126(01)00260-x.

DOI:10.1016/s0969-2126(01)00260-x
PMID:8591035
Abstract

BACKGROUND

The human 'protective protein' (HPP) forms a multi-enzyme complex with beta-galactosidase and neuraminidase in the lysosomes, protecting these two glycosidases from degradation. In humans, deficiency of HPP leads to the lysosomal storage disease galactosialidosis. Proteolytic cleavage of the precursor form of HPP involves removal of a 2 kDa excision peptide and results in a carboxypeptidase activity. The physiological relevance of this activity is, as yet, unknown.

RESULTS

The crystal structure of the 108 kDa dimer of the precursor HPP has been elucidated by making extensive use of twofold density averaging. The monomer consists of a 'core' domain and a 'cap' domain. Comparison with the distantly related wheat serine carboxypeptidase dimer shows that the two subunits in the HPP dimer differ by 15 degrees in mutual orientation. Also, the helical subdomain forming part of the cap domains is very different. In addition, the HPP precursor cap domain contains a 'maturation' subdomain of 49 residues which fills the active-site cleft. Merely removing the 'excision' peptide located in the maturation subdomain does not render the catalytic triad solvent accessible.

CONCLUSIONS

The activation mechanism of HPP is unique among proteases with known structure. It differs from the serine proteases in that the active site is performed in the zymogen, but is blocked by a maturation subdomain. In contrast to the zinc metalloproteases and aspartic proteases, the chain segment physically rendering the catalytic triad solvent inaccessible in HPP is not cleaved off to form the active enzyme. The activation must be a multi-step process involving removal of the excision peptide and major conformational changes of the maturation subdomain, whereas the conformation of the enzymatic machinery is probably almost, or completely, unaffected.

摘要

背景

人类“保护蛋白”(HPP)在溶酶体中与β-半乳糖苷酶和神经氨酸酶形成多酶复合物,保护这两种糖苷酶不被降解。在人类中,HPP缺乏会导致溶酶体贮积病半乳糖唾液酸贮积症。HPP前体形式的蛋白水解切割涉及去除一个2 kDa的切除肽,并产生羧肽酶活性。这种活性的生理相关性尚不清楚。

结果

通过广泛使用二次密度平均法阐明了108 kDa HPP前体二聚体的晶体结构。单体由一个“核心”结构域和一个“帽”结构域组成。与远缘相关的小麦丝氨酸羧肽酶二聚体比较表明,HPP二聚体中的两个亚基在相互取向上相差15度。此外,构成帽结构域一部分的螺旋亚结构域也非常不同。另外,HPP前体帽结构域包含一个由49个残基组成的“成熟”亚结构域,该亚结构域填充了活性位点裂隙。仅仅去除位于成熟亚结构域中的“切除”肽并不能使催化三联体暴露于溶剂中。

结论

HPP的激活机制在已知结构的蛋白酶中是独特的。它与丝氨酸蛋白酶的不同之处在于,活性位点在酶原中就已形成,但被一个成熟亚结构域阻断。与锌金属蛋白酶和天冬氨酸蛋白酶相反,在HPP中物理上使催化三联体无法暴露于溶剂的链段不会被切割掉以形成活性酶。激活必须是一个多步骤过程,涉及切除肽的去除和成熟亚结构域的主要构象变化,而酶促机制的构象可能几乎或完全不受影响。

相似文献

1
Three-dimensional structure of the human 'protective protein': structure of the precursor form suggests a complex activation mechanism.人类“保护蛋白”的三维结构:前体形式的结构提示了一种复杂的激活机制。
Structure. 1995 Nov 15;3(11):1249-59. doi: 10.1016/s0969-2126(01)00260-x.
2
Cathepsin A/protective protein: an unusual lysosomal multifunctional protein.组织蛋白酶A/保护蛋白:一种独特的溶酶体多功能蛋白。
Cell Mol Life Sci. 1999 Dec;56(11-12):894-907. doi: 10.1007/s000180050482.
3
Lysosomal high molecular weight multienzyme complex.溶酶体高分子量多酶复合体
Cell Mol Biol Lett. 2003;8(1):19-24.
4
Homologous modeling of the lysosomal protective protein/carboxypeptidase L: structural and functional implications of mutations identified in galactosialidosis patients.溶酶体保护蛋白/羧肽酶L的同源建模:半乳糖唾液酸贮积症患者中鉴定出的突变的结构和功能意义
Proteins. 1994 Jan;18(1):81-93. doi: 10.1002/prot.340180110.
5
Lysosomal multienzyme complex: biochemistry, genetics, and molecular pathophysiology.溶酶体多酶复合体:生物化学、遗传学及分子病理生理学
Prog Nucleic Acid Res Mol Biol. 2001;69:81-114. doi: 10.1016/s0079-6603(01)69045-7.
6
Direct affinity purification and supramolecular organization of human lysosomal cathepsin A.人溶酶体组织蛋白酶A的直接亲和纯化及超分子组装
Arch Biochem Biophys. 1994 Aug 15;313(1):64-70. doi: 10.1006/abbi.1994.1359.
7
Stable expression of protective protein/cathepsin A-green fluorescent protein fusion genes in a fibroblastic cell line from a galactosialidosis patient. Model system for revealing the intracellular transport of normal and mutated lysosomal enzymes.保护性蛋白/组织蛋白酶A-绿色荧光蛋白融合基因在一名半乳糖唾液酸贮积症患者的成纤维细胞系中的稳定表达。揭示正常和突变溶酶体酶细胞内运输的模型系统。
Biochem J. 1999 Jun 1;340 ( Pt 2)(Pt 2):467-74. doi: 10.1042/bj3400467.
8
Human lysosomal beta-galactosidase-cathepsin A complex: definition of the beta-galactosidase-binding interface on cathepsin A.人溶酶体β-半乳糖苷酶-组织蛋白酶A复合物:组织蛋白酶A上β-半乳糖苷酶结合界面的定义
Biochemistry. 1995 Feb 28;34(8):2431-40. doi: 10.1021/bi00008a005.
9
The atomic model of the human protective protein/cathepsin A suggests a structural basis for galactosialidosis.人类保护性蛋白/组织蛋白酶A的原子模型为半乳糖唾液酸贮积症提出了结构基础。
Proc Natl Acad Sci U S A. 1998 Jan 20;95(2):621-5. doi: 10.1073/pnas.95.2.621.
10
Lysosomal multienzyme complex: pros and cons of working together.溶酶体多酶复合物:协同工作的利弊。
Cell Mol Life Sci. 2014 Jun;71(11):2017-32. doi: 10.1007/s00018-013-1538-3. Epub 2013 Dec 15.

引用本文的文献

1
Novel CTSA Variant Identified in a Thai Family With Late-Infantile Galactosialidosis.在一个患有晚发性婴儿型半乳糖唾液酸贮积症的泰裔家庭中发现新型CTSA变异体。
Ann Hum Genet. 2025 May;89(2-3):126-131. doi: 10.1111/ahg.12595. Epub 2025 Apr 1.
2
Structure of the immunoregulatory sialidase NEU1.免疫调节神经氨酸酶 NEU1 的结构。
Sci Adv. 2023 May 19;9(20):eadf8169. doi: 10.1126/sciadv.adf8169.
3
In Silico Structural Analysis of Serine Carboxypeptidase 314, a Potential Drug Target in Infections.丝氨酸羧肽酶 314 的计算机结构分析,一种感染潜在药物靶点。
Int J Mol Sci. 2022 Oct 13;23(20):12203. doi: 10.3390/ijms232012203.
4
The Elastin Receptor Complex: An Emerging Therapeutic Target Against Age-Related Vascular Diseases.弹性蛋白受体复合物:一种针对与年龄相关的血管疾病的新兴治疗靶点。
Front Endocrinol (Lausanne). 2022 Feb 11;13:815356. doi: 10.3389/fendo.2022.815356. eCollection 2022.
5
Structure of the murine lysosomal multienzyme complex core.小鼠溶酶体多酶复合体核心的结构
Sci Adv. 2021 May 12;7(20). doi: 10.1126/sciadv.abf4155. Print 2021 May.
6
Galactosialidosis: preclinical enzyme replacement therapy in a mouse model of the disease, a proof of concept.半乳糖唾液酸贮积症:疾病小鼠模型中的临床前酶替代疗法,一项概念验证研究。
Mol Ther Methods Clin Dev. 2020 Nov 20;20:191-203. doi: 10.1016/j.omtm.2020.11.012. eCollection 2021 Mar 12.
7
Carboxypeptidase Y activity and maintenance is modulated by a large helical structure.羧肽酶 Y 的活性和维持受到一个大型螺旋结构的调节。
FEBS Open Bio. 2019 Jul;9(7):1337-1343. doi: 10.1002/2211-5463.12686. Epub 2019 Jun 17.
8
Distinctive structural motifs co-ordinate the catalytic nucleophile and the residues of the oxyanion hole in the alpha/beta-hydrolase fold enzymes.独特的结构基序协调了α/β-水解酶折叠酶中的催化亲核体和氧阴离子穴的残基。
Protein Sci. 2019 Feb;28(2):344-364. doi: 10.1002/pro.3527. Epub 2018 Nov 12.
9
Endocytosis and Enamel Formation.内吞作用与牙釉质形成
Front Physiol. 2017 Jul 31;8:529. doi: 10.3389/fphys.2017.00529. eCollection 2017.
10
Development of transgenic Brassica juncea lines for reduced seed sinapine content by perturbing phenylpropanoid pathway genes.通过干扰苯丙烷类途径基因培育种子芥酸含量降低的转基因芥菜型油菜品系。
PLoS One. 2017 Aug 7;12(8):e0182747. doi: 10.1371/journal.pone.0182747. eCollection 2017.